Efavirenz Conceptions and Regimen Management in a Prospective Cohort of Women on Antiretroviral Therapy

• Hoofdauteurs: Sheree Schwartz (Auteur), Taha E. Taha (Auteur), Willem Daniel Francois Venter (Auteur), Shruti Mehta (Auteur), Helen Rees (Auteur), Vivian Black (Auteur)
• Formaat: Boek
• Gepubliceerd in: Hindawi Limited, 2012-01-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Use of the antiretroviral drug efavirenz (EFV) is not recommended by the WHO or South African HIV treatment guidelines during the first trimester of pregnancy due to potential fetal teratogenicity; there is little evidence of how clinicians manage EFV-related fertility concerns. Women on antiretrovi...